Optiver Holding
GSK icon

Optiver Holding’s GSK GSK Stock Holding History

Optiver Holding’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.7M Buy
394,300
+57,200
+17% +$3.03M 0.01% 322
2026
Q1 		$18.6M Sell
337,100
-17,600
-5% -$954K 0.01% 288
2025
Q4 		$17.4M Buy
354,700
+13,600
+4% +$634K 0.01% 266
2025
Q3 		$14.7M Sell
341,100
-218,500
-39% -$8.53M 0.01% 251
2025
Q2 		$21.5M Buy
559,600
+46,400
+9% +$1.77M 0.01% 147
2025
Q1 		$19.9M Buy
513,200
+136,200
+36% +$4.99M 0.01% 139
2024
Q4 		$12.8M Sell
377,000
-72,400
-16% -$2.61M 0.01% 181
2024
Q3 		$18.4M Sell
449,400
-212,800
-32% -$8.71M 0.01% 189
2024
Q2 		$25.5M Sell
662,200
-214,300
-24% -$9.01M 0.01% 193
2024
Q1 		$37.8M Buy
876,500
+249,400
+40% +$10.3M 0.02% 171
2023
Q4 		$23.2M Buy
627,100
+35,100
+6% +$1.26M 0.01% 218
2023
Q3 		$21.5M Buy
592,000
+42,700
+8% +$1.52M 0.01% 223
2023
Q2 		$19.4M Sell
549,300
-575,000
-51% -$20.6M 0.01% 224
2023
Q1 		$39.6M Buy
1,124,300
+531,700
+90% +$18.6M 0.03% 185
2022
Q4 		$20.6M Buy
592,600
+122,200
+26% +$4.07M 0.02% 186
2022
Q3 		$13.7M Buy
470,400
+199,440
+74% +$7.56M 0.01% 169
2022
Q2 		$14.6M Sell
270,960
-77,920
-22% -$4.3M 0.02% 144
2022
Q1 		$19M Sell
348,880
-1,160,640
-77% -$63M 0.02% 118
2021
Q4 		$77.3M Buy
1,509,520
+840,400
+126% +$43.7M 0.07% 79
2021
Q3 		$31.6M Buy
669,120
+97,920
+17% +$4.92M 0.03% 92
2021
Q2 		$28.4M Buy
+571,200
New +$27.4M 0.04% 83
2021
Q1 		– Hold
0
– – – 85

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Optiver Holding's GSK Position: Q2 2026 in Review

Optiver Holding reduced its GSK (GSK) stake by 94% in Q2 2026, selling an estimated $12.7M and leaving 15,941 shares worth $836K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Optiver Holding first reported a position in GSK in Q4 2021 and has held it in 9 quarters since. The position peaked at $38.7M in Q4 2023. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Optiver Holding held 15,941 shares of GSK worth $836K as of Q2 2026.
  • Optiver Holding sold 239,333 GSK shares in Q2 2026, an estimated $12.7M.
  • GSK made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #671 holding.
  • Optiver Holding first reported a position in GSK in Q4 2021 and has held it in 9 quarters since.
  • Optiver Holding's GSK position peaked at $38.7M in Q4 2023.
  • 1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.